MIR100HG was previously reported to act as a regulator of hematopoiesis and oncogenes in many cancers (Emmrich et al., 2014; Nair, 2016; Shang et al., 2016; Wieczorek and Reszka, 2018; Zhang et al., 2018). This evidence concerns the gene MIR100HG and cancer.